AAAAAA

   
Results: 1-25 | 26-33
Results: 1-25/33
PHASE-I TRIAL OF CREMOPHOR EL WITH BOLUS DOXORUBICIN
Authors: MILLWARD MJ WEBSTER LK RISCHIN D STOKES KH TONER GC BISHOP JF OLVER IN LINAHAN BM LINSENMEYER NE WOODCOCK DM
Citation: Mj. Millward et al., PHASE-I TRIAL OF CREMOPHOR EL WITH BOLUS DOXORUBICIN, Clinical cancer research, 4(10), 1998, pp. 2321-2329
PHASE-II STUDY OF ACIVICIN IN PATIENTS WITH RECURRENT HIGH-GRADE ASTROCYTOMA
Authors: OLVER IN GREEN M MILLWARD MJ BISHOP JF
Citation: In. Olver et al., PHASE-II STUDY OF ACIVICIN IN PATIENTS WITH RECURRENT HIGH-GRADE ASTROCYTOMA, Journal of clinical neuroscience, 5(1), 1998, pp. 46-48
2ND LINE TREATMENT OPTIONS IN ADVANCED COLORECTAL-CANCER
Authors: STEWART JM MILLWARD MJ ZALCBERG JR
Citation: Jm. Stewart et al., 2ND LINE TREATMENT OPTIONS IN ADVANCED COLORECTAL-CANCER, European journal of cancer, 34(7), 1998, pp. 953-955
RANDOMIZED, CROSS-OVER TRIAL TO DETERMINE THE EFFECT OF CREMOPHOR ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF CARBOPLATIN-BASED THERAPY
Authors: MILLWARD MJ WEBSTER LK RISCHIN D ELLIS AG LINAHAN BM MAISANO R TONER GC STOKES KH
Citation: Mj. Millward et al., RANDOMIZED, CROSS-OVER TRIAL TO DETERMINE THE EFFECT OF CREMOPHOR ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF CARBOPLATIN-BASED THERAPY, Annals of oncology, 9, 1998, pp. 499-499
REPETITIVE HIGH-DOSE THERAPY WITH IFOSFAMIDE, THIOTEPA AND PACLITAXEL(ITP) WITH BLOOD-CELL (BC) SUPPORT FOR METASTATIC BREAST-CANCER (MBC)- RESULTS OF A PHASE-I STUDY
Authors: PRINCE HM MILLWARD MJ RISCHIN D BLAKEY D WOLF M JANUSCEWICZ H TONER G BERTONCELLO I RICHARDSON G BRIGGS P SCARLETT J GATES P DALE B
Citation: Hm. Prince et al., REPETITIVE HIGH-DOSE THERAPY WITH IFOSFAMIDE, THIOTEPA AND PACLITAXEL(ITP) WITH BLOOD-CELL (BC) SUPPORT FOR METASTATIC BREAST-CANCER (MBC)- RESULTS OF A PHASE-I STUDY, Experimental hematology, 26(8), 1998, pp. 65-65
ISOLEX 300I CD34-SELECTED BLOOD-CELLS (BC) ARE CAPABLE OF SUPPORTING MULTIPLE CYCLES OF HIGH-DOSE CHEMOTHERAPY
Authors: PRINCE HM BERTONCELLO I MILLWARD MJ CHAPPLE P RISCHIN D QUINN M BRETTELL M BARBER L WOLF M JANUSZEWICZ H JUNEJA S GATES P VANKERKHOVEN M MAISANO R TONER GC
Citation: Hm. Prince et al., ISOLEX 300I CD34-SELECTED BLOOD-CELLS (BC) ARE CAPABLE OF SUPPORTING MULTIPLE CYCLES OF HIGH-DOSE CHEMOTHERAPY, Experimental hematology, 26(8), 1998, pp. 68-68
A PHASE-II TRIAL OF CARBOPLATIN AND ETOPOSIDE FOR RELAPSED OR METASTATIC CARCINOMA OF THE CERVIX
Authors: TEBBUTT N RISCHIN D QUINN M ROME R MILLWARD MJ TONER GC BISHOP JF
Citation: N. Tebbutt et al., A PHASE-II TRIAL OF CARBOPLATIN AND ETOPOSIDE FOR RELAPSED OR METASTATIC CARCINOMA OF THE CERVIX, Australian and New Zealand Journal of Obstetrics and Gynaecology, 38(1), 1998, pp. 87-90
ACTIVITY OF GEMCITABINE IN STAGE-3 OR STAGE-4 OVARIAN-CANCER - PATIENTS PREVIOUSLY TREATED WITH CISPLATIN (CP)-CONTAINING REGIMENS
Authors: FRIEDLANDER M DEGRAMONT A MILLWARD MJ BELL D BUGAT R HARNETT P MORENO JA CAMPBELL L RIPOCHE V KAYITALIRE L
Citation: M. Friedlander et al., ACTIVITY OF GEMCITABINE IN STAGE-3 OR STAGE-4 OVARIAN-CANCER - PATIENTS PREVIOUSLY TREATED WITH CISPLATIN (CP)-CONTAINING REGIMENS, European journal of cancer, 33, 1997, pp. 538-538
PHASE-I STUDY OF PACLITAXEL AND ORAL ETOPOSIDE IN PREVIOUSLY UNTREATED NON-SMALL-CELL AND EXTENSIVE SMALL-CELL LUNG-CANCER
Authors: BOYER MJ ZALCBERG J OLVER IN MILLWARD MJ RICHARDSON G MCKEAGE MJ
Citation: Mj. Boyer et al., PHASE-I STUDY OF PACLITAXEL AND ORAL ETOPOSIDE IN PREVIOUSLY UNTREATED NON-SMALL-CELL AND EXTENSIVE SMALL-CELL LUNG-CANCER, Annals of oncology, 8(5), 1997, pp. 485-489
PHASE-I TRIAL OF DOCETAXEL AND CISPLATIN IN PREVIOUSLY UNTREATED PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER
Authors: MILLWARD MJ ZALCBERG J BISHOP JF WEBSTER LK ZIMET A RISCHIN D TONER GC LAIRD J COSOLO W URCH M BRUNO R LORET C JAMES R BLANC C
Citation: Mj. Millward et al., PHASE-I TRIAL OF DOCETAXEL AND CISPLATIN IN PREVIOUSLY UNTREATED PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER, Journal of clinical oncology, 15(2), 1997, pp. 750-758
PLASMA-CONCENTRATIONS OF POLYSORBATE-80 MEASURED IN PATIENTS FOLLOWING ADMINISTRATION OF DOCETAXEL OR ETOPOSIDE
Authors: WEBSTER LK LINSENMEYER ME RISCHIN D URCH ME WOODCOCK DM MILLWARD MJ
Citation: Lk. Webster et al., PLASMA-CONCENTRATIONS OF POLYSORBATE-80 MEASURED IN PATIENTS FOLLOWING ADMINISTRATION OF DOCETAXEL OR ETOPOSIDE, Cancer chemotherapy and pharmacology, 39(6), 1997, pp. 557-560
FATAL PULMONARY TOXICITY RESULTING FROM TREATMENT WITH GEMCITABINE
Authors: PAVLAKIS N BELL DR MILLWARD MJ LEVI JA
Citation: N. Pavlakis et al., FATAL PULMONARY TOXICITY RESULTING FROM TREATMENT WITH GEMCITABINE, Cancer, 80(2), 1997, pp. 286-291
REPETITIVE HIGH-DOSE IFOSFAMIDE, THIOTEPA AND PACLITAXEL (ITP) WITH PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT - A NOVEL OUTPATIENT REGIMEN FOR METASTATIC AND LOCALLY ADVANCED BREAST-CANCER
Authors: PRINCE HM MILLWARD MJ RISCHIN DR BLAKEY D WOLF M JANUSCEWICZ H TONER G RICHARDSON G SHARKEY P DALE B
Citation: Hm. Prince et al., REPETITIVE HIGH-DOSE IFOSFAMIDE, THIOTEPA AND PACLITAXEL (ITP) WITH PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT - A NOVEL OUTPATIENT REGIMEN FOR METASTATIC AND LOCALLY ADVANCED BREAST-CANCER, Blood, 90(10), 1997, pp. 4575-4575
ACTIVITY AND TOXICITY OF DOCETAXEL (TAXOTERE(R)) IN WOMEN WITH PREVIOUSLY TREATED METASTATIC BREAST-CANCER
Authors: SHAPIRO JD MILLWARD MJ RISCHIN D DAVISON JD MICHAEL M FRANCIS PA GANJU V TONER GC
Citation: Jd. Shapiro et al., ACTIVITY AND TOXICITY OF DOCETAXEL (TAXOTERE(R)) IN WOMEN WITH PREVIOUSLY TREATED METASTATIC BREAST-CANCER, Australian and New Zealand Journal of Medicine, 27(1), 1997, pp. 40-44
CREMOPHOR PHARMACOKINETICS IN PATIENTS RECEIVING 3-HOUR, 6-HOUR, AND 24-HOUR INFUSIONS OF PACLITAXEL
Authors: RISCHIN D WEBSTER LK MILLWARD MJ LINAHAN BM TONER GC WOOLLETT AM MORTON CG BISHOP JF
Citation: D. Rischin et al., CREMOPHOR PHARMACOKINETICS IN PATIENTS RECEIVING 3-HOUR, 6-HOUR, AND 24-HOUR INFUSIONS OF PACLITAXEL, Journal of the National Cancer Institute, 88(18), 1996, pp. 1297-1301
PHASE-I STUDY OF PHARMACOLOGICALLY BASED DOSING OF CARBOPLATIN WITH FILGRASTIM SUPPORT IN WOMEN WITH EPITHELIAL OVARIAN-CANCER
Authors: LIND MJ GHAZALASWAD S GUMBRELL L FISHWICK K CRAIGS D MILLWARD MJ BAILEY NP DOREGREEN F CHAPMAN F SIMMONS D PROCTOR M OAKEY A ROBSON L MIDDLETON I MCCANN E SINHA D CALVERT AH
Citation: Mj. Lind et al., PHASE-I STUDY OF PHARMACOLOGICALLY BASED DOSING OF CARBOPLATIN WITH FILGRASTIM SUPPORT IN WOMEN WITH EPITHELIAL OVARIAN-CANCER, Journal of clinical oncology, 14(3), 1996, pp. 800-805
PHASE-II TRIAL OF A 3-HOUR INFUSION OF PACLITAXEL IN PREVIOUSLY UNTREATED PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER
Authors: MILLWARD MJ BISHOP JF FRIEDLANDER M LEVI JA GOLDSTEIN D OLVER IN SMITH JG TONER GC RISCHIN D BELL DR
Citation: Mj. Millward et al., PHASE-II TRIAL OF A 3-HOUR INFUSION OF PACLITAXEL IN PREVIOUSLY UNTREATED PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER, Journal of clinical oncology, 14(1), 1996, pp. 142-148
PLASMA ALCOHOL CONCENTRATIONS IN PATIENTS FOLLOWING PACLITAXEL INFUSION
Authors: WEBSTER LK CRINIS NA MORTON CG MILLWARD MJ
Citation: Lk. Webster et al., PLASMA ALCOHOL CONCENTRATIONS IN PATIENTS FOLLOWING PACLITAXEL INFUSION, Cancer chemotherapy and pharmacology, 37(5), 1996, pp. 499-501
ACTIVITY OF GEMCITABINE IN PATIENTS WITH ADVANCED OVARIAN-CANCER - RESPONSES SEEN FOLLOWING PLATINUM AND PACLITAXEL
Authors: SHAPIRO JD MILLWARD MJ RISCHIN D MICHAEL M WALCHER V FRANCIS PA TONER GC
Citation: Jd. Shapiro et al., ACTIVITY OF GEMCITABINE IN PATIENTS WITH ADVANCED OVARIAN-CANCER - RESPONSES SEEN FOLLOWING PLATINUM AND PACLITAXEL, Gynecologic oncology, 63(1), 1996, pp. 89-93
ASSOCIATION OF ACQUIRED PELGER-HUET ANOMALY WITH TAXOID THERAPY
Authors: JUNEJA SK MATTHEWS JP LUZINAT R FAN Y MICHAEL M RISCHIN D MILLWARD MJ TONER GC
Citation: Sk. Juneja et al., ASSOCIATION OF ACQUIRED PELGER-HUET ANOMALY WITH TAXOID THERAPY, British Journal of Haematology, 93(1), 1996, pp. 139-141
EFFECT OF THE PACLITAXEL VEHICLE, CREMOPHOR EL, ON THE PHARMACOKINETICS OF DOXORUBICIN AND DOXORUBICINOL IN MICE
Authors: WEBSTER LK COSSON EJ STOKES KH MILLWARD MJ
Citation: Lk. Webster et al., EFFECT OF THE PACLITAXEL VEHICLE, CREMOPHOR EL, ON THE PHARMACOKINETICS OF DOXORUBICIN AND DOXORUBICINOL IN MICE, British Journal of Cancer, 73(4), 1996, pp. 522-524
CARBOPLATIN DOSING BASED ON MEASUREMENT OF RENAL-FUNCTION - EXPERIENCE AT THE PETER-MACCALLUM-CANCER-INSTITUTE
Authors: MILLWARD MJ WEBSTER LK TONER GC BISHOP JF RISCHIN D STOKES KH JOHNSTON VK HICKS R
Citation: Mj. Millward et al., CARBOPLATIN DOSING BASED ON MEASUREMENT OF RENAL-FUNCTION - EXPERIENCE AT THE PETER-MACCALLUM-CANCER-INSTITUTE, Australian and New Zealand Journal of Medicine, 26(3), 1996, pp. 372-379
INTERIM RESULTS OF A PHASE-II TRIAL OF DOCETAXEL IN COMBINATION WITH CISPLATIN IN PATIENTS WITH METASTATIC OR LOCALLY ADVANCED NON-SMALL-CELL LUNG-CANCER (NSCLC)
Authors: ZALCBERG JR BISHOP JF MILLWARD MJ ZIMET A LAIRD J BARTER C SEWARD D MCKEAGE MJ FRIEDLANDER ML TONER G BERILLE J BLANC C
Citation: Jr. Zalcberg et al., INTERIM RESULTS OF A PHASE-II TRIAL OF DOCETAXEL IN COMBINATION WITH CISPLATIN IN PATIENTS WITH METASTATIC OR LOCALLY ADVANCED NON-SMALL-CELL LUNG-CANCER (NSCLC), European journal of cancer, 31A, 1995, pp. 1084-1084
PHASE-I AND PHARMACOKINETIC STUDY OF A WATER-SOLUBLE ETOPOSIDE PRODRUG, ETOPOSIDE PHOSPHATE (BMY-40481)
Authors: MILLWARD MJ NEWELL DR MUMMANENI V IGWEMEZIE LN BALMANNO K CHARLTON CJ GUMBRELL L LIND MJ CHAPMAN F PROCTOR M SIMMONDS D CANTWELL BMJ TAYLOR GA MCDANIEL C WINOGRAD B KAUL S BARBAIYA RH CALVERT AH
Citation: Mj. Millward et al., PHASE-I AND PHARMACOKINETIC STUDY OF A WATER-SOLUBLE ETOPOSIDE PRODRUG, ETOPOSIDE PHOSPHATE (BMY-40481), European journal of cancer, 31A(13-14), 1995, pp. 2409-2411
TOMUDEX (ZD1694) - RESULTS OF A RANDOMIZED TRIAL IN ADVANCED COLORECTAL-CANCER DEMONSTRATE EFFICACY AND REDUCED MUCOSITIS AND LEUKOPENIA
Authors: CUNNINGHAM D ZALCBERG JR RATH U OLVER I VANCUTSEM E SVENSSON C SEITZ JF HARPER P KERR D PEREZMANGA G AZAB M SEYMOUR L LOWERY K ACKLAND SP BASSER RL CLARKE SJ GOLDSTEIN D GREEN MD GRYGIEL JJ MCKENDRICK JJ MILLWARD MJ OLVER IN TATTERSALL MHN THOMSON DB JAKESZ R BUSET M TUENI EA VANCUTSEM EJD BAUER J BESKA F ADENIS A BRUNET R FRANCOIS E PAILLOT B ROUGIER P FINK UFW KNUTH KRA KOENIG HJ BOHME MWJ WANDER HE AMADORI D FRASSINETI L COCCONI G PASSALACQUA R FRIGERIO F BARNI S LUPORINI G LABIANCA R MARINI G ZANIBONI A KLEPP O TVEIT KM WIST E CANDEIAS OFR GOUVEIA JGP MARQUES JCN OLIVEIRA JML CAVALLI F DELMORE GD GOEDHALS L VOROBIOF DA ESTEVE AAI AGUILAR EA TORRES AA RUIPEREZ AC RUBIO ED SUREDA BM MANGA GP ALFONSO PG GUSTAVSSON B JEPPSON B MALMBERG M STARKHAMMAR H SVENSSON JH KEIZER HJ SCHORNAGEL JH OBRIEN M HARPER PG KERR DJ SCARFFE JH TYRELL CJ
Citation: D. Cunningham et al., TOMUDEX (ZD1694) - RESULTS OF A RANDOMIZED TRIAL IN ADVANCED COLORECTAL-CANCER DEMONSTRATE EFFICACY AND REDUCED MUCOSITIS AND LEUKOPENIA, European journal of cancer, 31A(12), 1995, pp. 1945-1954
Risultati: 1-25 | 26-33